ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE recommends Janssen’s Crohn’s Disease biological therapy
europeanpharmaceuticalreview
May 03, 2017The National Institute for Health and Care Excellence (NICE) has recommended Janssen‘s Stelara (ustekinumab) in its final appraisal determination as a treatment option for adult patients with moderately to severely active Crohn’s disease.
Pharma Sources Insight January 2025
